These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18094506)

  • 41. Mechanisms of osteoinduction/chondroinduction by demineralized bone.
    Glowacki J; Zhou S; Mizuno S
    J Craniofac Surg; 2009 Mar; 20 Suppl 1():634-8. PubMed ID: 19169155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ramping up endogenous defences against chronic kidney disease.
    Eddy AA
    Nephrol Dial Transplant; 2006 May; 21(5):1174-7. PubMed ID: 16574685
    [No Abstract]   [Full Text] [Related]  

  • 43. Emerging role of bone morphogenetic proteins in angiogenesis.
    David L; Feige JJ; Bailly S
    Cytokine Growth Factor Rev; 2009 Jun; 20(3):203-12. PubMed ID: 19502096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
    Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone morphogenetic protein 2 therapy for craniofacial surgery.
    Smith DM; Cooper GM; Mooney MP; Marra KG; Losee JE
    J Craniofac Surg; 2008 Sep; 19(5):1244-59. PubMed ID: 18812847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ectopic expression of delta FBJ murine osteosarcoma viral oncogene homolog B mediates transdifferentiation of adipose-like spheroids into osteo-like microtissues.
    Diaz Sanchez-Bustamante C; Kelm JM; Egermann M; Djonov V; Fussenegger M
    Tissue Eng Part A; 2008 Aug; 14(8):1377-94. PubMed ID: 18491952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others).
    Atzeni F; Sarzi-Puttini P; Bevilacqua M
    Rheum Dis Clin North Am; 2006 May; 32(2):413-26, viii. PubMed ID: 16716887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2.
    Uchida M; Agata H; Sagara H; Shinohara Y; Kagami H; Asahina I
    J Biomed Mater Res A; 2009 Oct; 91(1):84-91. PubMed ID: 18767063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure.
    Davies MR; Lund RJ; Hruska KA
    J Am Soc Nephrol; 2003 Jun; 14(6):1559-67. PubMed ID: 12761256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ambivalence of progenitor cells in vascular repair and plaque stability.
    Hristov M; Weber C
    Curr Opin Lipidol; 2008 Oct; 19(5):491-7. PubMed ID: 18769230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cementogenesis and the induction of periodontal tissue regeneration by the osteogenic proteins of the transforming growth factor-beta superfamily.
    Ripamonti U; Petit JC; Teare J
    J Periodontal Res; 2009 Apr; 44(2):141-52. PubMed ID: 18842117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Understanding abnormalities in vascular specification and remodeling.
    Enciso JM; Hirschi KK
    Pediatrics; 2005 Jul; 116(1):228-30. PubMed ID: 15995057
    [No Abstract]   [Full Text] [Related]  

  • 53. The expression of molecular mediators in the idiopathic cutaneous calcification and ossification.
    Kim SY; Choi HY; Myung KB; Choi YW
    J Cutan Pathol; 2008 Sep; 35(9):826-31. PubMed ID: 18422975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A transcriptional regulator of osteogenesis expressed in calcifying atherosclerotic plaques.
    Brindle NP
    Cardiovasc Res; 2001 Nov; 52(2):178-80. PubMed ID: 11684065
    [No Abstract]   [Full Text] [Related]  

  • 55. [Recent progress of BMSCs acting as seeding cell for tissue engineered cartilage].
    Xu S; Xu Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Feb; 22(2):163-6. PubMed ID: 18365611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Animal models for vascular calcification].
    Ikeda K; Nakagawa Y; Matsubara H
    Clin Calcium; 2010 Nov; 20(11):1663-8. PubMed ID: 21037386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant human bone morphogenetic protein-2 promotes the proliferation of mesenchymal stem cells in vivo and in vitro.
    Liu SB; Hu PZ; Hou Y; Li P; Cao W; Tian Q
    Chin Med J (Engl); 2009 Apr; 122(7):839-43. PubMed ID: 19493400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
    J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invited commentary.
    Iyoda A
    Ann Thorac Surg; 2005 Sep; 80(3):1032. PubMed ID: 16122480
    [No Abstract]   [Full Text] [Related]  

  • 60. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application.
    Abarrategi A; Moreno-Vicente C; Ramos V; Aranaz I; Sanz Casado JV; López-Lacomba JL
    Tissue Eng Part A; 2008 Aug; 14(8):1305-19. PubMed ID: 18491953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.